Abstract
The value of cardiac biomarkers in addition to clinical and angiographic characteristics and their optimal cutpoints to differentiate small from large myocardial infarction during hospitalization for ST-elevation myocardial infarction (STEMI) has not been well defined. We studied 1,596 patients
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
